Valuation: Clene Inc.

Market Cap 7.48Cr 6.55Cr 6.08Cr 5.59Cr 11Cr 721.33Cr 11Cr 72Cr 28Cr 352.96Cr 28Cr 27Cr 1.22TCr P/E 2026 *
-3.28x
P/E 2027 * -3.97x
Enterprise Value 6.14Cr 5.38Cr 4.99Cr 4.59Cr 8.64Cr 592.03Cr 8.77Cr 59Cr 23Cr 289.69Cr 23Cr 23Cr 1TCr EV / Sales 2026 *
296x
EV / Sales 2027 * 2.26x
Free-Float
82.94%
Yield 2026 *
-
Yield 2027 * -
1 day+0.60%
1 week-3.24%
Current month-5.36%
1 month-1.10%
3 months-11.34%
6 months+7.47%
Current year-0.77%
1 week 5.57
Extreme 5.5701
6.13
1 month 5.57
Extreme 5.5701
6.55
Current year 3.88
Extreme 3.88
8.67
1 year 3.25
Extreme 3.25
13.5
3 years 2.28
Extreme 2.2801
16.12
5 years 2.28
Extreme 2.2801
196.8
10 years 2.28
Extreme 2.2801
356.4
Manager TitleAgeSince
Chief Executive Officer 59 01/04/2013
Chief Tech/Sci/R&D Officer 67 01/01/2013
Director of Finance/CFO 57 01/02/2022
Director TitleAgeSince
Director/Board Member 78 01/03/2013
Chairman 65 19/05/2021
Director/Board Member 49 01/12/2020
Date Insider Type Main position Quantity % Market Cap.
11/06/26 Free

Founder

45,000 0.3522%
11/06/26 Free

Chief Financial Officer

15,000 0.1174%
11/06/26 Free

Chief Executive Officer

65,000 0.5087%
Change 5-day change 1-year change 3-year change Capi.($)
+0.60%-3.24%+52.89%-62.66% 7.48Cr
-0.43%-1.26%+52.13%+85.69% 5.56TCr
-0.24%+1.04%+55.76%+58.36% 5.43TCr
-0.49%-0.11%-17.54%-14.15% 2.33TCr
-1.93%-3.33%+3.14%+418.84% 2.35TCr
+0.05%+1.68%+38.71%-4.57% 2.03TCr
+3.16%+0.79%+37.98%-29.06% 1.74TCr
+1.08%+3.77%+36.92%+593.96% 1.56TCr
+0.43%-1.67%+166.53%+299.61% 1.5TCr
-1.86%-0.45%+24.35%+178.03% 1.41TCr
Average +0.04%-0.75%+45.09%+152.41% 2.39TCr
Weighted average by Cap. -0.17%-0.24%+43.69%+138.47%

Financials

2026 *2027 *
Net sales 2L 2L 2L 2L 3L 2Cr 3L 20.1L 8L 97.93L 8L 8L 3.38Cr 2.36Cr 2.07Cr 1.92Cr 1.77Cr 3.33Cr 228.15Cr 3.38Cr 23Cr 8.97Cr 111.64Cr 8.88Cr 8.68Cr 385.66Cr
Net income -2.51Cr -2.2Cr -2.04Cr -1.88Cr -3.53Cr -242.14Cr -3.59Cr -24Cr -9.52Cr -118.48Cr -9.42Cr -9.22Cr -409.3Cr -2.75Cr -2.41Cr -2.24Cr -2.06Cr -3.88Cr -265.82Cr -3.94Cr -27Cr -10Cr -130.07Cr -10Cr -10Cr -449.33Cr
Net Debt -1.34Cr -1.17Cr -1.09Cr -1Cr -1.89Cr -129.3Cr -1.92Cr -13Cr -5.08Cr -63Cr -5.03Cr -4.92Cr -218.57Cr -2.14Cr -1.88Cr -1.74Cr -1.6Cr -3.01Cr -206.5Cr -3.06Cr -21Cr -8.12Cr -101.04Cr -8.03Cr -7.86Cr -349.05Cr
Logo Clene Inc.
Clene Inc. is a clinical-stage pharmaceutical company, which is engaged in discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The CSN therapeutics are comprised of atoms of transition elements that, when assembled in nanocrystal form, possess unusually high, unique catalytic activities that do not present in those same elements in bulk form. CNM-Au8, the lead drug asset, is a concentrated aqueous suspension of catalytically active, clean-surfaced, faceted gold nanocrystals for the treatment of ALS, MS, and PD. CNM-Au8's mechanism of action targets mitochondrial dysfunction by catalyzing the production of nicotinamide adenine dinucleotide. Its CNM-ZnAg is an antiviral and antibacterial agent comprised of zinc (Zn2+) and silver (Ag+) ions in an aqueous solution to treat infectious disease and to provide immune support for symptom resolution.
Employees
78
Date Price Change Volume
22/26/22 $5.825 -0.43% 8,617
21/26/21 $5.850 +2.09% 72,499
20/26/20 $5.730 -3.21% 39,992
17/26/17 $5.920 +4.04% 83,174
16/26/16 $5.690 -5.48% 97,068
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
5.850USD
Average target price
32.20USD
Spread / Average Target
+450.43%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CLNN Stock